# Lilly reports third-quarter 2026 financial results, raises full-year guidance and highlights regulatory progress across the portfolio

> **Open Intelligence Dossier** · First detected: 2026-10-29 12:20 UTC · Category: Business

## Executive Summary
12 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.

## Intelligence Brief
&quot;Lilly reports third-quarter 2026 financial results, raises full-year guidance and highlights regulatory progress across the portfolio&quot; is generating significant coverage in the Business category, with 15 articles from 12 distinct sources tracked by PULSE so far.


Outlets currently covering the story include Crain&#039;s Chicago Business, Reuters, Yahoo Finance and WSJ. PULSE measures a story&#039;s velocity from how quickly new articles appear and how many independent newsrooms join the coverage.


This brief was generated by PULSE&#039;s extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.

## Multi-Source Evidence Table
| Source Outlet | Headline | Verification URL |
|---|---|---|
| Fierce Pharma | As Skyrizi and Rinvoq dominate AbbVie's Q3, analysts ask what's next | [Source Link](https://news.google.com/rss/articles/CBMipgFBVV95cUxPc2kyZTlXVXpESTYxa1lJMjRTcDd3Uklqc1hSMi1zUjNiVU4xRy1VY0ZBS2xHTDg4NlB1SGFabl9wQlVGU29pU0xOVFQyZzNWbjU1clNHeEhsb0wxNVF5aVlKeFJPNkxPTUI5Y3hNcU4zN2FvdHd4enRvM05nQW92QjF2aFpsWmhZbXh2QTNmQmF0Vmd4elQ4dE44TmJXZnBNVUFQUGN3?oc=5) |
| TradingView | LLY, ABBV Stocks Hit All-Time High – Here’s What’s Driving Investor Enthusiasm Today | [Source Link](https://news.google.com/rss/articles/CBMi2gFBVV95cUxOUGdCTlNmZm11LThkQWs5RXdYUngxXzJON2ZDVEFhQS1iQ0VIRXFZR1NMSG12QnpCaEluZGlHRnZ5ZFI2bDlYMC15MGgzT3JCSHBhYy03VDU5dXNZSHlZRXUyWk9GbUVjVW1ET01wQ0hfUldRaFllVzd6bnluY2M3ZXJJVTYxbV9FdzBoNl8yQXljVms2MHV3c3JuUlBHSTI3SWlCTTdBTkJyc1J6ODlHTlFxSW4xRDl5UEhCRkNDMlhmM1VlYUR6ZlFLZF9MYVI5Y0ltcXkxNXI3UQ?oc=5) |
| Yahoo Finance | Here's What Key Metrics Tell Us About AbbVie (ABBV) Q3 Earnings | [Source Link](https://news.google.com/rss/articles/CBMilAFBVV95cUxPT1hUb2VzV3pkNGxQVEgtNHRxWk9lTE96MVZHYWFnTWlxc2V3Q1luemFlNW13NEk4WWQ4UktQNkJvLVpsU09LbHE3ekloQl9DcnZ4R3V1Q250c1NYeFprUjVwa3VWU2ZXQ0wxbGFUMG9Wd2R4ZF80VXFiTXh4REljV1dMaWpQTW1kcGlzR0FEV282dnVD?oc=5) |
| Investor's Business Daily | AbbVie's Profit Doubles As Immunology King Beats Again | [Source Link](https://news.google.com/rss/articles/CBMihgFBVV95cUxQd0pZdmxRUWJrSzhPUU5ZNUl3dzNSSDJsSzBYY1JYMW55Y09wdTI4UWRPTHpPeFNlTWVyTThaTWxUSjA4UGJYZzJjRHMxb25VbWJoSkNmVUdTWGpNUUk1ZnNGd0ZDak5hejFnaDBDQ2dsSlVqTC15QW9IZHVOaWxJWndnSzlpZw?oc=5) |
| GuruFocus | AbbVie (ABBV) Set to Report Q3 Earnings Amid Dividend Sustainabi | [Source Link](https://news.google.com/rss/articles/CBMitAFBVV95cUxOVjM2QlNOTnA5ejUweUFOMnpkTFo1NzFoZDN2c1JEUXEtUGFfSkdtRXd1YXBXTEM1b3p1Sk5fRl9QZHowWm9VRkN0NnAzcjVTb2hieG9fSC1fZWtVSG8tZGdhMnVjR1JRZi0ySG1CS21iVEJqekZyWEN1ck1TYTNhU1llLVc2c3kybE9Kb05mSkJpa0pOdlhjQ1NTUnBIeHkxYW5uU0FlM0RKbTBNejFDMkRFbVA?oc=5) |
| Yahoo Finance | AbbVie beats estimates but stock dips | [Source Link](https://news.google.com/rss/articles/CBMimgFBVV95cUxOTHpBcmRsWVdFWXJmanVxcTJMb2o0dEZRTW5xYUZ0WXRZOFJNb1Vxa21QSDdBV21WRkVsaUVjaWEtTHdJaFlwcmsxMDJnZFRnQ1lqdVpCUDVYck44RWxvZng2cHl2cTRpWFlMXzVhRUJySlRZWHNlSm54aDJJVGl3bHNTdG13SUowZlJSMnliemFBNHRLckItN2Rn?oc=5) |
| Crain's Chicago Business | AbbVie’s earnings double as drugmaker eyes a move into obesity treatments | [Source Link](https://news.google.com/rss/articles/CBMijwFBVV95cUxOVVZET3hTWi1ZYjRXOHc0dmNhaEtmbEwtRzkydTRySzl4UXlIN3JvZXlZcm5ySGVHWDJfLS1SNUhDTnlLVkhaVUVvbkZJWTBRMlJzMnJBTDdDVXV6SWVhN3dSSmwtZzMtdWY4clMtSVY3VmNSZFRpMjRqQlpkeGRyS1FuNTVPR1g3MGo0RmpIUQ?oc=5) |
| Reuters | AbbVie lifts annual profit forecast as immunology drugs continue to fuel growth | [Source Link](https://news.google.com/rss/articles/CBMiuwFBVV95cUxPNjJPY3ZXYmJiVGxxQ3E4ZERuMXJwM2pnNEZRZmE2SVY1UVQ5bjg1Z25OTVV0VU1xc21LUkpmZWNQUmlBbU9keW9SV1M5ODRpRnVCQ25MU1ZPV1RzN2ptQW5oVHh5SldjZm1aSEtRY29MR3k1dVVBLXhFbVF0ZWNqUWlMZ1ZhdW5DM2lvTmVpdFJ0NEZncGV0Vk4wVV9IRDdrOHpOc1pCcGF0S2dkc0JFekppdzVXWjB0TUtV?oc=5) |
| Yahoo Finance | AbbVie: Q3 Earnings Snapshot | [Source Link](https://news.google.com/rss/articles/CBMilwFBVV95cUxQNnlPaFBURTZVQXJTaFgxNklGdlpHMVB4aWJySUp2LVgwLTNuelpMQlZPb1hoY2xFd0xLT0EtOVk5bXdzZkJveW0xWThwR1Q0VHk1aUpsVGM4VjlGcHlxVVdrN2VEX08tN19iYy03NnZISHBZWTNhajNoMy13Q0xFODg2MUJraW1wWVRDdjF2LThULVlDNlIw?oc=5) |
| WSJ | AbbVie Revenue Rises on Strength in Immunology, Neuroscience | [Source Link](https://news.google.com/rss/articles/CBMiqgFBVV95cUxOVHBFalVsU1c5dGxfMElsYjdWUkFPWXVTTDdJbDF6Vm1WekowQWZJVXpHS3MxYzExOXBvT3JfMlBsOVBodWVPdE9mVDAwQ0RRcFNlM3BNUXRKamotcG5wZVpPQXY2c243S25naUlyS3ZTd1lEY2QzSmpjUjJrcjRmazRBRmhnNjRrOTNrTnJrWGVYVUtrNEYtMUZ3OVFSc19vbHJENEpxMWtRUQ?oc=5) |
| AbbVie News Center | AbbVie Reports Third-Quarter 2026 Financial Results | [Source Link](https://news.google.com/rss/articles/CBMijwFBVV95cUxQbkJ1dThsWktBNWNpVjg0cXRkamIyVVBBZHdXaDRHdVFzUHJzUnBqQ1l6TV8xc3piTk1mNzJ2WTY0UklQLTUyQXhpNVZMSEZ5UWl0TGlMSlVLRThGbENxSjAzX0dzV2xjMUE5Nlc3UU5yb1c0TkNodVpvamR4N2lQWjlhaXNKX3lhZkllWnVwaw?oc=5) |
| Starbucks Investor Relations | Starbucks Reports Q4 and Full Fiscal Year 2026 Results | [Source Link](https://news.google.com/rss/articles/CBMi1wFBVV95cUxOdUlhMDJ2eXQ0cHlKNC1neEVaVVlxSEwwOHZjZHFhN3pPX3RfZ3VlY0lCQWI2RTJXZVEwSks0VHlsLU5GOUg1TXVLQURhcUR0UVB3bExTRVYzTXZTQzZPRHhfeWRiSmtPMDRneVFKVnpFbFZjNTNfVUU0bVFTYjNtMDI3dUVfQlJqVG1iMjVzOGRRRzBvRUt1b1EwZ214Q1pQUlFfZUVfczgtN0RLMU5xd0Nkem16TkV5Y2JhVjdEbGJBclFTdTNZbjZRSFlyblgtMWZJb3FKUQ?oc=5) |
| CNBC | Eli Lilly hikes sales outlook, as CEO says there's room for 'dramatic' obesity market expansion | [Source Link](https://news.google.com/rss/articles/CBMidkFVX3lxTE9NdFQ3UUxsNVQtQmtLandjang0Nk5QZ2xEb3B1TU11X2dYVUdVSUFNaTdLOGhCR3VTUVdlT19WY0VkVE1FMm9uUzhIckpsT1BmM1RVbUw1ZWJZVTJ3MVdxREZlVVlPRXZjTjMzTXoxWXhMaVpEQUE?oc=5) |
| Finimize | Eli Lilly’s Medicare Pilot Helps Fuel A $5 Billion Raise | [Source Link](https://news.google.com/rss/articles/CBMigwFBVV95cUxQOGlJTXliM1p5LXRQSVkxamF5TDFzdDBTR0NZUGVka1NCRnpjZUhNUFdqc0RFOHRMTHhoU2g2OE0xaXhyaFhrak5BNzRrT3dnb0FGcVdETXF0TzIwWmVIbGprWVpjUjNCOHpaSDVqM0ZhMnZiQWFHaXRfTXVrcHJtbml6SQ?oc=5) |
| TipRanks | Eli Lilly Stock (LLY) Soars as Financial Results Crush Wall Street Estimates | [Source Link](https://news.google.com/rss/articles/CBMipwFBVV95cUxPWm53ZmFVVjJ6Tl93R2N3dEpIU2piZFA0V01BRnVhRUJfQnpPLTR1QW10X1BfU3l3YmVzT3pEOGRtdTBwb0NoeGRKWlNENk5odmx1WjM2WDdxeE9STXE0ZktZZmdGVzZrbFB2OGZOOUJsbEpDN2syYzM4bTlSODJxb1hMSjZ1em1YeHZRUFo1Qm0tS0cyM2FEODFoX0V6WndSQkFLM18zbw?oc=5) |

---
*Canonical Source: https://pulse.byoaiapps.com/trend/2026-10-29/lilly-reports-third-quarter-2026-financial-results-raises-full-year-guidance*
